Literature DB >> 16854503

[Orthopedic manifestations of the antiphospholipid syndrome].

E Rosenthal1, S-R Sangle, M-A Khamashta, D D'Cruz, G-R-V Hughes.   

Abstract

PURPOSE: The antiphospholipid syndrome (APS) is characterized by arterial and/or venous thrombosis, and pregnancy morbidity in association with antiphospholipid antibodies. Since its classical description 22 years ago, the clinical spectrum of APS has embraced the realms of obstetrics, nephrology, cardiology, neurology, gastroenterology, angiology and now, possibly orthopaedics. This is not surprising given that this disease can affect virtually any organ system and blood vessel of any size and nature. Just as venous thrombosis may affect limbs and internal organs, arterial thrombosis has been shown to affect organs such as the brain, eye, heart, kidney, liver and may also involve the skeleton. CURRENT KNOWLEDGE AND KEY POINTS: In this review, we describe the orthopedic aspects of APS recently reported, bone metatarsal fractures, osteonecrosis and more exceptional complications, ie algodystrophy and bone marrow necrosis. We briefly discuss postulated pathogenesis and possible implications of anticoagulation. FUTURE PROSPECTS AND PROJECTS: This data need further confirmation. They may suggest complementary physiopathologic and therapeutic implications.

Entities:  

Mesh:

Year:  2006        PMID: 16854503     DOI: 10.1016/j.revmed.2006.05.019

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  2 in total

1.  Multifocal avascular necrosis revealing antiphospholipid syndrome.

Authors:  Samira Rostom; Rachid Bahiri; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2007-09-01       Impact factor: 2.980

2.  Salmonella osteomyelitis complicating aseptic osteonecrosis: Don't forget about the antiphospholipid syndrome.

Authors:  Fatma Daoud; Imène Rachdi; Olfa Frikha; Mohamed Ben Salah; Soumaya Charaa; Hana Zoubeidi; Mehdi Somai; Khaled Hadhri; Mondher Kooli; Chiraz Chammakhi; Fatma Boussema
Journal:  Clin Case Rep       Date:  2021-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.